MedPath

COLESEVELAM HYDROCHLORIDE

These highlights do not include all the information needed to use COLESEVELAM HYDROCHLORIDE safely and effectively. See full prescribing information for COLESEVELAM HYDROCHLORIDE. COLESEVELAM HYDROCHLORIDE tablets, for oral use COLESEVELAM HYDROCHLORIDE for oral suspension Initial U.S. Approval: 2000

Approved
Approval ID

40d66c9d-ff51-4353-8133-ae3a8eb4f713

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 28, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

COLESEVELAM HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-6994
Application NumberNDA021176
Product Classification
M
Marketing Category
C73594
G
Generic Name
COLESEVELAM HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 12, 2022
FDA Product Classification

INGREDIENTS (5)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
COLESEVELAM HYDROCHLORIDEActive
Quantity: 625 mg in 1 1
Code: P4SG24WI5Q
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

COLESEVELAM HYDROCHLORIDE - FDA Drug Approval Details